Xevant, the leader and creator of automated data analytics for organizations managing pharmacy benefits, is pleased to announce the completion of a new investment round with HCAP Partners, a California-based private equity firm and nationally recognized impact investor.
As the most comprehensive, independent pharmacy analytics platform available, Xevant offers pharmacy benefit managers, payers, hospitals, and consultants customized solutions with the ability to streamline decades-old analytic processes – ultimately resulting in lower drug costs and optimized performance and efficiencies. With this latest round of investment, the company will further expand its unique position to positively impact pharmacy benefit stakeholders and advance its long-held mission of revolutionizing healthcare services with its real-time automation platform.
“Xevant’s innovative solutions and talented team of experts are changing the way that access, quality, and cost issues are approached by healthcare stakeholders,” said Frank Mora, HCAP Senior Partner. “We are excited to enter this partnership as the company embarks on the next phase of its growth journey and continues to bring world class solutions to market.”
Brandon Newman, Xevant CEO, commented, “The successful completion of our latest investment round is a testament to the strength and potential of Xevant. This new infusion of capital will enable us to accelerate our growth plans, expand our team, and continue delivering cutting-edge solutions that drive value and improve outcomes in healthcare. We are grateful for the support and confidence from HCAP Partners and look forward to the exciting opportunities ahead.”
Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!
